Published in J Neurochem on May 15, 2007
The Noncanonical Role of ULK/ATG1 in ER-to-Golgi Trafficking Is Essential for Cellular Homeostasis. Mol Cell (2016) 1.49
Serotonin and blood pressure regulation. Pharmacol Rev (2012) 1.41
Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol Interv (2010) 1.23
Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11
Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol (2012) 1.01
A serotonergic system in veins: serotonin transporter-independent uptake. J Pharmacol Exp Ther (2008) 0.96
Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol (2007) 0.94
Conditioned pain modulation is associated with common polymorphisms in the serotonin transporter gene. PLoS One (2011) 0.90
5-hydroxtryptamine receptors in systemic hypertension: an arterial focus. Cardiovasc Ther (2011) 0.89
The role of circulating serotonin in the development of chronic obstructive pulmonary disease. PLoS One (2012) 0.88
Communication between 5-HT and small GTPases. Curr Opin Pharmacol (2011) 0.87
5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved. BMC Pharmacol (2012) 0.86
The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network. PLoS One (2009) 0.86
Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.85
The role of ERp44 in maturation of serotonin transporter protein. J Biol Chem (2012) 0.84
One-month serotonin infusion results in a prolonged fall in blood pressure in the deoxycorticosterone acetate (DOCA) salt hypertensive rat. ACS Chem Neurosci (2012) 0.84
Antidepressants and anti-inflammatory drugs differentially reduce the release of NGF and BDNF from rat platelets. Pharmacopsychiatry (2012) 0.83
Serotonin: a different player in hypertension-associated thrombosis. Hypertension (2015) 0.81
GDM-associated insulin deficiency hinders the dissociation of SERT from ERp44 and down-regulates placental 5-HT uptake. Proc Natl Acad Sci U S A (2014) 0.81
Effect of serotonin on platelet function in cocaine exposed blood. Sci Rep (2014) 0.80
Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes. PLoS One (2013) 0.80
Differential expression of 5-HT-related genes in symptomatic pulmonary embolism patients. Int J Clin Exp Med (2015) 0.79
Serotonin-induced down-regulation of cell surface serotonin transporter. Neurochem Int (2014) 0.79
Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss). Am J Physiol Heart Circ Physiol (2016) 0.79
Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability. Sci Rep (2016) 0.79
Protective effects of fluoxetine on decompression sickness in mice. PLoS One (2012) 0.78
Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation. Alcohol Clin Exp Res (2009) 0.78
Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice. Health (Irvine Calif) (2013) 0.77
Comparison of the function of the serotonin transporter in the vasculature of male and female rats. Clin Exp Pharmacol Physiol (2011) 0.76
Differential patterning of genes involved in serotonin metabolism and transport in extra-embryonic tissues of the mouse. Placenta (2016) 0.76
Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function. PLoS One (2016) 0.76
Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior. Genes Brain Behav (2013) 0.76
Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta. J Biol Chem (2016) 0.76
Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse. Eur J Pharmacol (2008) 0.76
Modeling serotonin uptake in the lung shows endothelial transporters dominate over cleft permeation. Am J Physiol Lung Cell Mol Physiol (2013) 0.75
Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant. Front Physiol (2016) 0.75
The 5-hydroxytryptamine transporter is functional in human coronary artery smooth muscle cells proliferation and is regulated by Interleukin-1 beta. Int J Clin Exp Med (2015) 0.75
Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation. Sci Rep (2016) 0.75
Postural orthostatic tachycardia syndrome is associated with platelet storage pool deficiency. Medicine (Baltimore) (2016) 0.75
Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor. J Biol Chem (2016) 0.75
Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets. J Am Heart Assoc (2017) 0.75
5-Hydroxytryptamine Changes under Different Pretreatments on Rat Models of Myocardial Infarction and/or Depression. Chin Med J (Engl) (2017) 0.75
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Cloning and expression of a functional serotonin transporter from rat brain. Nature (1991) 2.86
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A (1993) 2.80
The pharmacology of 5-hydroxytryptamine (serotonin). J Pharmacol Exp Ther (1952) 2.36
Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J (2003) 2.22
A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol (2003) 2.15
Cloning of a serotonin transporter affected by antidepressants. Science (1991) 2.12
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med (1991) 2.06
Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem (1993) 1.93
Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (1999) 1.85
Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation (2002) 1.71
Regulating the conducting states of a mammalian serotonin transporter. Neuron (2003) 1.55
Oligomerization of serotonin transporter and its functional consequences. Proc Natl Acad Sci U S A (2000) 1.49
Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol (2003) 1.38
Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci (1999) 1.35
Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem (2004) 1.33
5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond) (2005) 1.29
Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation (2004) 1.18
Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA. J Biol Chem (1999) 1.17
5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol (2006) 1.15
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res (2001) 1.08
Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J Biol Chem (2003) 1.00
Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J Neurochem (2003) 0.98
Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension (1986) 0.94
More pieces of the platelet activation puzzle slide into place. J Clin Invest (1999) 0.93
Serotonin and vasoconstrictor synergism. Life Sci (1998) 0.93
Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood (1984) 0.91
Intracellular signaling involved in estrogen regulation of serotonin reuptake. Mol Cell Endocrinol (2004) 0.90
Pharmacological modulation of platelet function in hypertension. Hypertension (2003) 0.87
Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Tex Heart Inst J (1995) 0.83
Relevance of platelet serotonergic mechanisms in pregnancy induced hypertension. Life Sci (1994) 0.81
Platelet activation is increased in cyclosporin A-induced hypertensive rats. J Cardiovasc Pharmacol (2000) 0.80
Pharmacotherapy of intermittent claudication. Expert Opin Pharmacother (2001) 0.80
Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents. Life Sci I (1973) 0.80
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. J Thromb Haemost (2003) 0.80
Factors influencing platelet serotonin uptake in essential hypertension. Int J Cardiol (1992) 0.79
Hypertension increases the contractions to sumatriptan in the human internal mammary artery. Ann Thorac Surg (1996) 0.79
Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. Eur J Pharmacol (1987) 0.79
[Free serotonin level in the blood of patients with borderline and essential hypertension]. Kardiol Pol (1990) 0.79
3H-imipramine binding in the blood platelets of normal twins. Psychiatry Res (1990) 0.78
Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry (1994) 0.78
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats. Thromb Res (1995) 0.78
Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens (1988) 0.77
Prevalence of coronary artery disease in Asian Indians. Am J Cardiol (1992) 2.90
Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res (1999) 1.76
Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol (1999) 1.74
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation (2000) 1.71
Gadolinium-enhanced MR cisternography to evaluate dural leaks in intracranial hypotension syndrome. AJNR Am J Neuroradiol (2007) 1.63
Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation (1994) 1.63
Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res (2001) 1.61
Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol (1990) 1.58
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol (2000) 1.57
Funding for biomedical research: What happened to our share of the nation's wealth? Chest (1998) 1.40
Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J (1996) 1.20
Evaluation of venous and arterial conduit patency by 16-slice spiral computed tomography. Circulation (2004) 1.19
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet (2003) 1.12
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation (2000) 1.12
Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol (1998) 1.10
Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am J Physiol Heart Circ Physiol (2001) 1.09
Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol (1998) 1.07
Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J (1999) 1.05
Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol (1990) 1.04
Pleuropericarditis and pericardial tamponade associated with inflammatory bowel disease. J Ark Med Soc (2005) 1.04
A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease. Qual Saf Health Care (2005) 1.03
Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1998) 1.02
Vitamins C and E prolong time to arterial thrombosis in rats. J Nutr (1999) 1.01
Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters. J Neurochem (2003) 0.98
Exercise and myocardial tolerance to ischaemia-reperfusion. Acta Physiol Scand (2004) 0.95
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. Am J Physiol Heart Circ Physiol (2006) 0.95
Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun (2000) 0.94
Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol (1997) 0.94
Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol (1996) 0.94
Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Role of P-selectin. Arterioscler Thromb Vasc Biol (1995) 0.92
Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo. Gene Ther (2010) 0.92
Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler Thromb Vasc Biol (1999) 0.92
Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1). J Pharmacol Exp Ther (1999) 0.91
Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients. Am Heart J (1985) 0.90
Peritonitis due to Pseudomonas stutzeri, an organism that may be difficult to culture. Perit Dial Int (2010) 0.89
Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins. J Mol Cell Cardiol (1988) 0.89
Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. Am J Physiol (1998) 0.89
Tumor necrosis factor-alpha enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C. Cardiovasc Res (1999) 0.89
Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital. Clin Cardiol (2002) 0.88
Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb Res (1994) 0.88
Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. Circulation (1987) 0.87
Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator. J Am Coll Cardiol (1992) 0.87
Traditional risk factors and acute myocardial infarction in patients hospitalized with cocaine-associated chest pain. Clin Cardiol (2007) 0.87
Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Ther (1996) 0.87
Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury. Gene Ther (2007) 0.86
Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation (2000) 0.86
Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J Lab Clin Med (1990) 0.86
Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release. J Pharmacol Exp Ther (1991) 0.86
Anti-thrombotic effects of atorvastatin--an effect unrelated to lipid lowering. J Cardiovasc Pharmacol Ther (2002) 0.86
Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ Res (2001) 0.86
LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse. Gene Ther (2011) 0.85
Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids (1991) 0.85
Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. Circulation (1997) 0.85
Co-purification of 130 kD nitric oxide synthase and a 22 kD link protein from human neutrophils. Biochem Biophys Res Commun (1992) 0.84
Inhibitory effect of high-density lipoprotein on platelet function is mediated by increase in nitric oxide synthase activity in platelets. Life Sci (1994) 0.83
TGF-beta(1) modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol (2001) 0.83
Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. Am J Physiol (1997) 0.83
Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation. Am J Physiol (1999) 0.83
Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide. Br J Pharmacol (1997) 0.83
Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res (1994) 0.83
[New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases]. Clin Ter (2007) 0.83
Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J Cardiovasc Pharmacol (1996) 0.82
Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia (2005) 0.82
Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. Circ Res (1998) 0.81
Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus. Am J Cardiol (1990) 0.81
Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Hypertension (2001) 0.81
Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol. Arch Intern Med (1987) 0.81
Radio-guided occult lesion localisation for breast lesions under computer-aided MRI guidance: the first experience and initial results. Br J Radiol (2011) 0.81
Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res (2000) 0.81
Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther (2002) 0.81
Angiotensin-converting enzyme inhibitor-induced pancreatitis. Clin Cardiol (1999) 0.81
Serum lidocaine concentrations following application to the oropharynx: effects of cimetidine. Ther Drug Monit (1987) 0.80
Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J (1995) 0.80
Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc Res (1999) 0.80
Mathematical estimation of the potential effect of vascular remodelling/dilatation on B-mode ultrasound intima-medial thickness. QJM (2004) 0.80
Plasma treatment of polyurethane coating for improving endothelial cell growth and adhesion. J Biomater Sci Polym Ed (2005) 0.80
Effects of exercise-induced oxidative stress on nitric oxide release and antioxidant activity. Am J Cardiol (1997) 0.80
Platelet inhibitory effect of nitroglycerin in platelet-rich plasma: relevance of glutathione-s-transferases in plasma. J Investig Med (1996) 0.80
The advantages of MRI and MRA for diagnosing Behçet's disease and internal jugular vein thrombosis. Comput Med Imaging Graph (2000) 0.80
Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol (1991) 0.79
Endothelium-dependent relaxation of rat aortic rings by leukotriene D4: importance of the magnitude of preload. Eicosanoids (1989) 0.79
Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Am J Physiol (1988) 0.79
Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting. Preliminary results of the effect of papaverine. J Thorac Cardiovasc Surg (1984) 0.79
Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med (1990) 0.79
5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1. Am J Physiol (1992) 0.79
Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism. Am J Cardiol (1985) 0.79
Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J (1993) 0.79
Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart disease. Indian Heart J (2001) 0.79
Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors. Ther Adv Cardiovasc Dis (2012) 0.79
Effects of aspirin in arterial thrombosis: why don't animals behave the way humans do? J Am Coll Cardiol (1993) 0.78
Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation (1996) 0.78
Nitric oxide synthase in adult red blood cells: vestige of an earlier age or a biologically active enzyme? J Lab Clin Med (2000) 0.78
Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits. Biochem Biophys Res Commun (2001) 0.78
Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis. Clin Cardiol (2000) 0.78
Modulation of cardiovascular remodeling with statins: fact or fiction? Curr Vasc Pharmacol (2005) 0.78
Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis. Cardiovasc Res (1995) 0.78
Leukotriene D4 potentiates the contractile effects of epinephrine and norepinephrine on rat aortic rings. J Pharmacol Exp Ther (1988) 0.78
Nonplatelet-mediated effects of aspirin. Drugs Today (Barc) (2002) 0.78
Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and superoxide dismutase activity. J Cardiovasc Pharmacol (2000) 0.78
HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells. J Viral Hepat (2006) 0.78